683 Capital Management, LLC - 22 Sep 2025 SCHEDULE 13G Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH)

Filing Manager
683 Capital Management, LLC
Reporting Manager
683 CAPITAL MANAGEMENT, LLC
Security
REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share
Symbol
RVPH
Shares outstanding
101,399,254 shares
Disclosed Ownership
5,435,000 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
29 Sep 2025, 18:59:03 UTC
Date of event
22 Sep 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"683 Capital Management, LLC disclosed 5.4% ownership in REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH) on 22 Sep 2025."

Quick Takeaways

  • 683 Capital Management, LLC filed SCHEDULE 13G for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH).
  • Disclosed ownership: 5.4%.
  • Date of event: 22 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 29 Sep 2025, 18:59.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
683 CAPITAL MANAGEMENT, LLC 5.4% 5,435,000 0 5,435,000 /s/ Ari Zweiman Ari Zweiman, Managing Member
683 CAPITAL PARTNERS, LP 5.4% 5,435,000 0 5,435,000 /s/ Ari Zweiman Ari Zweiman, Authorized Person
Zweiman Ari 5.4% 5,435,000 0 5,435,000 /s/ Ari Zweiman Ari Zweiman, Self

Sponsored